Pharma Marketing Blog:
In my presentation before the FDA at yesterday's public hearing, I made some specific suggestions, including the use of an FDA-designated hash tag to be included in each branded Tweet posted by pharmaceutical companies. If each product was assigned a unique hash tag by the FDA and all product tweets were required to include (Read More)
Pharma Marketing Blog:
Only the following 13 FDA panel members will be able to ask questions during this week's public hearing on the use of social media by the pharmaceutical industry:Thomas W. Abrams - Director, Division of Drug Marketing, Advertising, and Communications (DDMAC) - Center for Drug Evaluation, and Research (CDER)Kathryn J. Aikin (Read More)
Pharma Marketing Blog:
At eyeforpharma's eCommunication & Online Marketing Summit, the audience had a lot of questions about the upcoming FDA public hearing. At one point, the discussion turned to the nature of the speakers for this hearing versus the 1996 hearing. I prepared the following chart to illustrate the differences:There are some inter (Read More)
Pharma Marketing Blog:
As you no doubt know, FDA is hosting a public hearing on pharma's use of social media for Rx drug (and device) promotion next week (see here). I will be making two presentations at that meeting (see speaker schedule here):9:30-9:45 AM on Thursday, Nov 12 (following PhRMA)10:20-10:30 AM on Friday, Nov 13You can find my prese (Read More)
Pharma Marketing Blog:
Many pharma eMarketing pundits and FDA policy wonks out there are already predicting that nothing much will come out of the upcoming public hearing on Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools (see "FDA Announces Public Hearing on Promotion of Drugs on Int (Read More)
Pharma Marketing Blog:
Let me make a prediction: FDA's DDMAC will issue some version of draft guidance on the use of social medial for Rx drug/device promotion BEFORE the end of 2010. Just for the record, I tweeted about this last week (October 21, 2009; see here).Yesterday, at the ePatient Connections 2009 conference, I was a member of the Regul (Read More)
Pharma Marketing Blog:
We were somewhere around Bethesda on the edge of Washington, DC when reality began to take hold. I remember saying something like "I feel a bit lightheaded; maybe you should drive..." And suddenly there was a terrible roar all around us and the sky was full of what looked like huge bats, all swooping and screeching and divi (Read More)
Pharma Marketing Blog:
In preparation for FDA's public hearing on the Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools, the agency is asking for comments on 19 specific questions (see "Let's Respond to FDA's Questions Regarding Its Regulation of Social Media"). These questions are incl (Read More)
Pharma Marketing Blog:
In preparation for FDA's public hearing on the Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools, the agency is asking for comments on 19 specific questions (see "Let's Respond to FDA's Questions Regarding Its Regulation of Social Media"). These questions are incl (Read More)
Pharma Marketing Blog:
Have you heard of sidewiki? Sidewiki is Google's new browser sidebar that "enables you to contribute and read helpful information alongside any web page. It is available as a feature in Google Toolbar" (You can find Google sidewiki here).The "helpful information" Google is talking about is sidewiki entries that other people (Read More)
Pharma Marketing Blog:
In preparation for FDA's public hearing on the Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools, the agency is asking for comments on 19 specific questions (see "Let's Respond to FDA's Questions Regarding Its Regulation of Social Media"). These questions are incl (Read More)
Pharma Marketing Blog:
The FDA is asking for comments from the public about how it should regulate drug promotion on social network sites (see survey/questionnaire). Several of the questions FDA asks concerns the issue of monitoring, processing, and reporting adverse events that are found on social media sites (see here, here, and here). The phar (Read More)
Pharma Marketing Blog:
In preparation for FDA's public hearing on the Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools, the agency is asking for comments on 19 specific questions (see "Let's Respond to FDA's Questions Regarding Its Regulation of Social Media"). These questions are incl (Read More)
Pharma Marketing Blog:
Are some pharma marketers so focused on figuring out how to promote brands via social media that they are not seeing the plainly obvious unbranded opportunities out there?Some time ago, I accused Novo Nordisk of engaging in Twitter "spam" when it posted a Levemir-branded tweet via its @racewithinsulin twitter account (see " (Read More)
Pharma Marketing Blog:
It was the best of times [for the Internet], it was the worst of times [for newspapers].For the first time that I can remember, the pharmaceutical industry is spending more of its DTC advertising budget on Internet display ads (excluding search) than on newspapers (see chart below; source is TNS Media Intelligence). [We're (Read More)